Selected article for: "clinical outcome and co infection"

Author: Shahid, Zubair; Karim, Nadia; Shahid, Fakhar; Yousaf, Zohaib
Title: COVID-19 Associated Imported Plasmodium vivax Malaria Relapse: First Reported Case and Literature Review
  • Cord-id: kkouvlc9
  • Document date: 2021_5_10
  • ID: kkouvlc9
    Snippet: Plasmodium vivax (P. vivax) is a protozoan parasite that causes vivax malaria. Disease relapse post-treatment is reported in P. vivax co-infection with other bacterial and parasitic infections, but Plasmodium vivax reactivation is not very common with viral infections. Early recognition and diagnosis of a Plasmodium vivax malaria relapse in a non-endemic region pose a diagnostic dilemma. COVID-19 co-infection compounds this dilemma due to overlapping symptoms. Early diagnosis and treatment are e
    Document: Plasmodium vivax (P. vivax) is a protozoan parasite that causes vivax malaria. Disease relapse post-treatment is reported in P. vivax co-infection with other bacterial and parasitic infections, but Plasmodium vivax reactivation is not very common with viral infections. Early recognition and diagnosis of a Plasmodium vivax malaria relapse in a non-endemic region pose a diagnostic dilemma. COVID-19 co-infection compounds this dilemma due to overlapping symptoms. Early diagnosis and treatment are essential for a favorable clinical outcome. We report a middle-aged gentleman with high-grade fever and headaches who had COVID-19 and was found to have a relapse of Plasmodium vivax malaria.

    Search related documents:
    Co phrase search for related documents
    • Try single phrases listed below for: 1